← All stocks

Royalty Pharma plc

RPRXPharmaceuticalsLatest filing used: 2026-11-04Filings on SEC EDGAR ↗

Fair value per share

No filings-based value

Too few comparable years of filings.

Last close

$69.31

Nov 13, 2026

How we decide

Ten years of results

Revenue

$2.4B in FY2025, up 5% on the year before

FY2018: $1.8BFY2019: $1.8BFY2020: $2.1BFY2021: $2.3BFY2022: $2.2BFY2023: $2.4BFY2024: $2.3BFY2025: $2.4B$1.2B$2.5BFY18FY19FY22FY25$2.4B
Show as table
YearRevenue
FY2018$1.8B
FY2019$1.8B
FY2020$2.1B
FY2021$2.3B
FY2022$2.2B
FY2023$2.4B
FY2024$2.3B
FY2025$2.4B

Dividends per share

$0.84 a share in FY2024

FY2020: $0.30FY2021: $0.68FY2022: $0.76FY2023: $0.80FY2024: $0.84$0.5$1FY18FY19FY22FY25$0.84
Show as table
YearDividends per share
FY2018–
FY2019–
FY2020$0.30
FY2021$0.68
FY2022$0.76
FY2023$0.80
FY2024$0.84
FY2025–

Shares outstanding

Share count rose 50% over 7 years

FY2020: 375MFY2021: 415MFY2022: 438MFY2023: 603MFY2024: 594MFY2025: 564M0400M800MFY18FY19FY22FY25564.5M
Show as table
YearShares outstanding
FY2018–
FY2019–
FY2020375M
FY2021415M
FY2022438M
FY2023603M
FY2024594M
FY2025564M

No cash earnings in the filings.

Delayed quote

Delayed price and chart from TradingView. This site does not receive or store these prices, and the fair value above does not use them. Showing the chart sends TradingView this page's address, the widget type, the ticker and your IP address, and TradingView may collect analytics; see Privacy.

Open on Yahoo Finance ↗

Sources. Company figures: SEC EDGAR (XBRL filings), latest filing used 2026-11-04. Interest rate: U.S. Treasury, 10-year par yield, 2026-11-13. Last close: IEX Historical Data, 2026-11-13.